These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11524661)

  • 21. Efficacy and safety of γ-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: a case report.
    Caputo F; Bernardi M; Zoli G
    J Clin Psychopharmacol; 2011 Feb; 31(1):140-1. PubMed ID: 21192167
    [No Abstract]   [Full Text] [Related]  

  • 22. Depression Following γ-Hydroxybutyrate Withdrawal: A Case Report.
    Domínguez I; Bruguera P; Balcells-Oliveró M; Batalla A
    J Clin Psychopharmacol; 2015 Oct; 35(5):618-9. PubMed ID: 26284931
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of gamma-hydroxybutyrate withdrawal.
    Sharma AN; Lombardi MH; Illuzzi FA; Nelson LS
    Ann Emerg Med; 2001 Nov; 38(5):605-7. PubMed ID: 11679881
    [No Abstract]   [Full Text] [Related]  

  • 24. [Severe delirium in withdrawal from chronic gamma-hydroxybutyric acid consumption].
    Proest G; Zschernack T; Stelzig M; Steinacher B
    Nervenarzt; 2009 May; 80(5):607-8. PubMed ID: 19252889
    [No Abstract]   [Full Text] [Related]  

  • 25. Gamma-hydroxybutyrate withdrawal syndrome.
    Dyer JE; Roth B; Hyma BA
    Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drosophila metabolize 1,4-butanediol into gamma-hydroxybutyric acid in vivo.
    Satta R; Dimitrijevic N; Manev H
    Eur J Pharmacol; 2003 Jul; 473(2-3):149-52. PubMed ID: 12892832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient accelerated idioventricular rhythm after 1,4-butanediol exposure.
    Stefani M; Fulde S; McCrohon J; Roberts DM
    Clin Toxicol (Phila); 2020 Nov; 58(11):1071-1072. PubMed ID: 32134692
    [No Abstract]   [Full Text] [Related]  

  • 28. [Life threatening symptoms of withdrawal of gamma-hydroxybutyrate].
    Veerman SR; Dijkstra HN; Liefting-Kluft I
    Tijdschr Psychiatr; 2010; 52(6):411-6. PubMed ID: 20544599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression by 1,3-butanediol of the ethanol withdrawal syndrome in rats.
    Majchrowicz E; Hunt WA; Piantadosi C
    Science; 1976 Dec; 194(4270):1181-2. PubMed ID: 1033604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diazepam in the treatment of GHB dependence.
    Addolorato G; Caputo F; Capristo E; Gasbarrini G
    Br J Psychiatry; 2001 Feb; 178():183. PubMed ID: 11157447
    [No Abstract]   [Full Text] [Related]  

  • 31. [GHB withdrawal delirium].
    Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
    Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypernatremia caused by treatment with GHB obtained via a doctor's prescription].
    Rood IM; Seijger CG; van Waarde JA; de Maat MM; Verhave JC; Blans MJ
    Tijdschr Psychiatr; 2017; 59(1):47-51. PubMed ID: 28098924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,4-Butanediol content of aqua dots children's craft toy beads.
    Suchard J; Nizkorodov S; Wilkinson S
    J Med Toxicol; 2009 Sep; 5(3):120-4. PubMed ID: 19655283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival of massive gamma-hydroxybutyrate/1,4-butanediol overdose.
    Strickland RM; Felgate P; Caldicott DG
    Emerg Med Australas; 2005 Jun; 17(3):281-3. PubMed ID: 15953232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GHB: its use and misuse.
    Harv Ment Health Lett; 2001 Mar; 17(9):7-8. PubMed ID: 11276153
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification and quantitation of 1,4-butanediol in mammalian tissues: an alternative biosynthetic pathway for gamma-hydroxybutyric acid.
    Barker SA; Snead OC; Poldrugo F; Liu CC; Fish FP; Settine RL
    Biochem Pharmacol; 1985 May; 34(10):1849-52. PubMed ID: 4004901
    [No Abstract]   [Full Text] [Related]  

  • 37. Excited delirium syndrome after withdrawal from 10 days long recreationally used GHB.
    Corstens D
    J Forensic Leg Med; 2018 Feb; 54():74-75. PubMed ID: 29328965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic 1,4-butanediol treatment in rats: cross-tolerance to gamma-hydroxybutyrate and (+/-)-baclofen.
    Eckermann KA; Koek W; France CP
    Eur J Pharmacol; 2004 Jan; 484(2-3):259-62. PubMed ID: 14744611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
    McDonough M; Kennedy N; Glasper A; Bearn J
    Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,4-Butanediol dimethanesulfonate.
    National Toxicology Program
    Rep Carcinog; 2011; 12():77-8. PubMed ID: 21850117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.